Researchers examined the psychosocial impact of circulating tumor DNA testing in early-stage colorectal cancer survivors from three randomized trials, focusing on how this emerging prognostic biomarker influences fear of cancer recurrence. (Psycho-Oncology)
CRC Research Finding
The CRC Digest